Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease

被引:7
作者
Verdalles, Ursula [1 ]
Goicoechea, Marian [1 ]
Garcia de Vinuesa, Soledad [1 ]
Quiroga, Borja [1 ]
Galan, Isabel [1 ]
Verde, Eduardo [1 ]
Perez de Jose, Ana [1 ]
Luno, Jose [1 ]
机构
[1] Hosp Gen Univ Gregorio, Dept Nefrol, Madrid, Spain
来源
NEFROLOGIA | 2016年 / 36卷 / 05期
关键词
Resistant hypertension; Prevalence; Chronic kidney disease; Diuretics; Spironolactone; LIPID-LOWERING TREATMENT; BLOOD-PRESSURE CONTROL; ARTERIAL-HYPERTENSION; CONTROLLED-TRIAL; SPIRONOLACTONE; EFFICACY;
D O I
10.1016/j.nefro.2016.04.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Resistant hypertension (RH) is a common problem in patients with chronic kidney disease (CKD). A decline in the glomerular filtration rate (GFR) and increased albuminuria are associated with RH; however, there are few published studies about the prevalence of this entity in patients with CKD. Objective: To estimate the prevalence of RH in patients with different degrees of kidney disease and analyse the characteristics of this group of patients. Methods: A total of 618 patients with hypertension and CKD stages I-IV were enrolled, of which 82 (13.3%) met the criteria for RH. Results: RH prevalence increased significantly with age, the degree of CKD and albuminuria. The prevalence of RH was 3.2% in patients under 50 years, 13.8% between 50-79 years and peaked at 17.8% in patients older than 80 years. Renal function prevalence was 4, 15.8 and 18.1% in patients with an estimated glomerular filtration rate (GFR) of > 60, 30-59 and < 30 ml/min/1.73 m(2), respectively, and 8.9, 15.9 and 22.5% for a urine albumin to creatinine ratio (UACR) < 30, 30-299 and > 300 mg/g respectively. In a logistic regression model, the characteristics associated with resistant hypertension were age, history of cardiovascular disease, GFR, albuminuria and diabetes mellitus. A total of 47.5% of patients with resistant hypertension had controlled BP (<140/90 mmHg) with 4 or more antihypertensive drugs. These patients were younger, with better renal function, less albuminuria and received more aldosterone antagonists. Conclusion: RH prevalence increases with age, the degree of CKD and albuminuria. Strategies such as treatment with aldosterone receptor antagonists are associated with better blood pressure control in this group of patients, leading to reduced prevalence. (C) 2016 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:523 / 529
页数:7
相关论文
共 23 条
[1]   A Controlled Trial of Renal Denervation for Resistant Hypertension [J].
Bhatt, Deepak L. ;
Kandzari, David E. ;
O'Neill, William W. ;
D'Agostino, Ralph ;
Flack, John M. ;
Katzen, Barry T. ;
Leon, Martin B. ;
Liu, Minglei ;
Mauri, Laura ;
Negoita, Manuela ;
Cohen, Sidney A. ;
Oparil, Suzanne ;
Rocha-Singh, Krishna ;
Townsend, Raymond R. ;
Bakris, George L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) :1393-1401
[2]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[3]   Hypertension in renal parenchymal disease: Why is it so resistant to treatment? [J].
Campese, VM ;
Mitra, N ;
Sandee, D .
KIDNEY INTERNATIONAL, 2006, 69 (06) :967-973
[4]   Effect of spironolactone on blood pressure in subjects with resistant hypertension [J].
Chapman, Neil ;
Dobson, Joanna ;
Wilson, Sarah ;
Dahlof, Bjorn ;
Sever, Peter S. ;
Wedel, Hans ;
Poulter, Neil R. .
HYPERTENSION, 2007, 49 (04) :839-845
[5]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[6]   Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J].
Cushman, William C. ;
Ford, Charles E. ;
Einhorn, Paula T. ;
Wright, Jackson T., Jr. ;
Preston, Richard A. ;
Davis, Barry R. ;
Basile, Jan N. ;
Whelton, Paul K. ;
Weiss, Robert J. ;
Bastien, Arnaud ;
Courtney, Donald L. ;
Hamilton, Bruce P. ;
Kirchner, Kent ;
Louis, Gail T. ;
Retta, Tamrat M. ;
Vidt, Donald G. .
JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (10) :751-760
[7]   Refractory Hypertension: Definition, Prevalence, and Patient Characteristics [J].
Czarina Acelajado, Maria ;
Pisoni, Roberto ;
Dudenbostel, Tanja ;
Dell'Italia, Louis J. ;
Cartmill, Falynn ;
Zhang, Bin ;
Cofield, Stacey S. ;
Oparil, Suzanne ;
Calhoun, David A. .
JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (01) :7-12
[8]   Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring [J].
de la Sierra, Alejandro ;
Segura, Julian ;
Banegas, Jose R. ;
Gorostidi, Manuel ;
de la Cruz, Juan J. ;
Armario, Pedro ;
Oliveras, Anna ;
Ruilope, Luis M. .
HYPERTENSION, 2011, 57 (05) :898-U74
[9]   Resistant Hypertension: Demography and Clinical Characteristics in 6292 Patients in a Primary Health Care Setting [J].
Gijon-Conde, Teresa ;
Graciani, Auxiliadora ;
Banegas, Jose R. .
REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (04) :270-276
[10]  
Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x